Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications association host pharmacodynamic effects virologic response pegylated interferon alfa
… their crucial role in addressing health disparities. In response, the FDA has issued a call for pharmaceutical …
… outcomes particularly in oncology studies, with numerous publications in this area. Her experience spans both the … language. Ms. Odom is a member of the American Statistical Association and the International Society of …
… race on MenACWY vaccine uptake was likely captured by the association of race with poverty, geographic area, and access …
What Factors Influence Health Equity - or Inequity? Share on: September 26, 2023 Image Article contributed by: Chad Downey, BS Associate Director, Project and Proposal Operations Chair, RTI-HS Diversity and Inclusion Advisory Council Co-chair, RTI …
Keith Aldridge Manchester, United Kingdom AS, Associate Chartered Institute of Management Accountants, London, United Kingdom BA, Accounting with Combined Studies (Business Law, Industrial Economics and Quantitative Methods in Business) University of …
Differences and Similarities of Health Economic Evaluation for Medical Technologies by HTA Bodies Vijay D'Souza, PhD Senior Associate, Market Access and Outcomes Strategy Transcript In recent years, an increasing number of medical technologies such as …
About As a business unit of RTI International , we provide global biopharmaceutical companies research and consulting services in health economics, patient-centered outcomes research, market access, and pharmacoepidemiology. As the only non-profit, …
New Patient-Reported Outcomes Diary for Rare Acromegaly Disorder Share on: February 27, 2023 Acromegaly Symptom Diary Acromegaly is a rare but serious condition caused by pituitary tumors that result in overabundance of growth hormone and insulin-like …
… comparison, survival analysis, utility analysis, dose response and multivariate regression analysis and repeated … of severe respiratory diseases. This research led to four publications in peer reviewed journals, including CHEST, …
FORTEO® Post-Market Osteosarcoma Surveillance Program: Real-World Data Contributes to Label Change Share on: January 25, 2021 The US Food and Drug Administration (FDA) is no longer requiring a black box warning on the label for the drug FORTEO® …